Every year, thousands of medical students across the United States submit residency applications through the Electronic Residency Application Service, the centralized platform known as ERAS that funnels applications from medical schools to training programs in every specialty. For a small but growing subset of those students, a single specialty is no longer enough. A new research letter published in the Archives of Dermatological Research examines the phenomenon of dual-specialty applications among dermatology applicants, using cross-sectional data from the ERAS specialty dashboard covering the 2022 to 2026 application cycles. The study, led by Lauren Fleshner and June Moon of New York Medical College together with colleagues at the University of Connecticut and the University of Florida, offers one of the most systematic looks yet at how often aspiring dermatologists are simultaneously applying to other fields, and why that trend matters for the future of the specialty.
Dermatology has long occupied a peculiar position in American graduate medical education. It is consistently among the most competitive specialties in the National Resident Matching Program, the algorithm-driven process that pairs applicants with training positions. The combination of a limited number of residency slots, desirable lifestyle characteristics, and strong career prospects means that the ratio of applicants to positions is among the highest in medicine. For students, that competition translates into anxiety, and anxiety, in turn, translates into strategy. One of the most visible strategies is the dual application: submitting materials not only to dermatology programs but also to a second specialty, typically one perceived as less competitive, as a hedge against the possibility of not matching.
The technical foundation of the new analysis is the ERAS specialty dashboard, a publicly accessible data product maintained by the Association of American Medical Colleges. The dashboard aggregates application statistics by specialty and by cycle, allowing researchers to track how many applicants to a given specialty also designated applications to other specialties in the same cycle. By pulling these figures for each application year from 2022 through 2026, the research team was able to construct a five-year cross-sectional picture of dual-application behavior among dermatology applicants. Because the data are publicly available, the study required no institutional review board approval, and the authors have made supplemental methods and data available through a public repository to allow independent verification of their analysis.
The appeal of such an approach is its transparency. Rather than relying on surveys, which are vulnerable to recall bias and to the reluctance of applicants to admit hedging behavior, the ERAS dashboard captures what applicants actually did when they submitted their applications. That distinction matters, because dual applications are a sensitive topic. Advisors and program directors have debated for years whether applying to two specialties signals genuine interest in both fields or a lack of commitment to either, and whether such applications dilute the applicant pool or simply reflect rational behavior under uncertainty. Administrative data sidestep those confessions and report the behavior directly.
The context in which this research appears is one of mounting pressure on the residency pipeline. The Association of American Medical Colleges has repeatedly projected a continuing shortage of physicians in the United States, a forecast that has intensified scrutiny of how medical students choose specialties and how residency programs select trainees. At the same time, the total number of applications submitted per applicant has risen across many specialties, a phenomenon that has been criticized for inflating competition and straining program review capacity. Against that backdrop, dual applications occupy an ambiguous position: from the applicant’s perspective they are a risk-management tool, but from the perspective of specialties and programs they complicate the interpretation of application numbers and may distort the apparent competitiveness of a field.
The ethical dimension of the trend has not gone unnoticed. A companion commentary by several overlapping authors, published in the Journal of the American Academy of Dermatology, explores the implications of dual-specialty applications for medical student advisors, raising questions about the duty advisors owe to students who are torn between fields, and about the fairness of a system in which well-advised students can hedge while others cannot. The research letter and the commentary together frame dual applications not merely as a statistical curiosity but as a structural feature of the match ecosystem that deserves deliberate policy attention rather than informal folklore.
For dermatology specifically, the stakes are concrete. Program directors rely on application data to gauge interest, to set screening thresholds, and to decide how to allocate interview invitations. If a meaningful fraction of dermatology applicants are simultaneously pursuing another specialty, the raw applicant count may overstate the number of candidates who would actually accept a dermatology position, while the number of applications per applicant may inflate the workload of reviewing programs. Conversely, applicants who dual apply face their own dilemmas: how to present a credible narrative of commitment to two different fields, how to schedule audition rotations and letters of recommendation across specialties, and how to answer the inevitable interview question about which specialty they truly prefer.
The study’s timeframe is itself significant. The 2022 to 2026 window spans a period of unusual turbulence in graduate medical education, encompassing the aftermath of the pandemic-era shift to virtual interviews, ongoing debates about the role of United States Medical Licensing Examination scores in screening, and growing adoption of holistic review practices that de-emphasize quantitative metrics in favor of broader assessment of candidates. Each of these shifts alters the calculus that applicants use when deciding whether to hedge. A student who might once have relied on a strong Step score to secure dermatology interviews may now face more uncertainty about how they will be evaluated, and uncertainty is precisely the condition that drives dual applications.
The researchers also situate their work within a broader effort to demystify the dermatology application process. A recent multi-part series in Clinics in Dermatology has examined the path forward for the specialty, including holistic review, equity and inclusion, and post-match solutions, reflecting a specialty-wide recognition that the current system produces stress for applicants and inefficiency for programs. The new ERAS dashboard analysis contributes an empirical baseline to that conversation: before stakeholders can evaluate whether dual applications are rising, stabilizing, or falling, and before they can design interventions, they need reliable descriptive data on the scale of the phenomenon. That is precisely what a cross-sectional analysis of five consecutive application cycles provides.
What emerges from the study is a portrait of a specialty at an inflection point. Dermatology remains a destination field, but the behavior of its applicants reveals the strategic adaptations that extreme competition produces. Dual-specialty applications are the visible signature of that adaptation, and the ERAS specialty dashboard offers a way to monitor it year by year without burdening applicants with additional surveys. The authors, who report no funding and no competing interests, frame their work as a descriptive contribution intended to inform advisors, program directors, and national organizations as they weigh reforms to the application process. Whether the appropriate response is better advising, changes to how programs screen applications, or structural reforms to the match itself remains an open question, but the study makes clear that the question can no longer be answered anecdotally. With public data now covering half a decade of applicant behavior, the conversation about dual applications in dermatology can move from speculation to evidence, and the specialty can begin to decide whether hedging is a problem to be solved or simply a rational response to a system that applicants did not design.
Subject of Research: Dual-specialty residency application trends among dermatology applicants in the ERAS system
Article Title: Trends in dual-specialty applications among dermatology applicants: a cross-sectional analysis from 2022 to 2026 of the ERAS specialty dashboard
Article References: Fleshner, L., Moon, J., Klufas, T., Zhou, A. E., Grant-Kels, J. M., & Klufas, D. M. (2026). Trends in dual-specialty applications among dermatology applicants: a cross-sectional analysis from 2022 to 2026 of the ERAS specialty dashboard. Archives of Dermatological Research, 318(1), Article 523. https://doi.org/10.1007/s00403-026-04996-8
Image Credits: AI Generated
DOI: 10.1007/s00403-026-04996-8
Keywords: dermatology, residency match, ERAS, dual-specialty applications, medical education, NRMP, AAMC, application trends, physician workforce, holistic review, international medical graduates, USMLE
News Source: Dean Parker. (October 13, 2026). Dermatology Applicants Increasingly Hedge Their Bets With Dual-Specialty Applications. Scienmag.
